Clinical trial INCB62079-101
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | Incyte Corporate |
EudraCT Identifier | 2017-001153-13 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03144661 |
Inclusion criteria | after standard therapy |
Last update |